FDA says Wyeth recalling one lot of Prevnar vaccine

Dow Jones Newswire (7/17, Dooren) reports, "The US Food and Drug Administration said Wyeth is recalling one lot of its pediatric Prevnar vaccine after the company discovered a portion of the lot contained material not intended for commercial use." The company stated that if "concluded that the affected syringes present no health or safety risk to patients and that there is no need to revaccinate." A company spokeswoman said that "the recall affects 96,280 doses although the company believes that most of the doses have already been used." She explained that Wyeth "determined that 16,000 doses of one lot of pre-filled syringes, which was not intended for commercial use, was inadvertently packaged and distributed with commercial product.

<Read more about recent drug news from Mouwasat Medical Services Pharmacy NewsLetter>